David K Lerner, Katherine L Garvey, Annie Arrighi-Allisan, Evan Kominsky, Andrey Filimonov, Abdurrahman Al-Awady, Peter Filip, Katherine Liu, Sen Ninan, Todd Spock, Benjamin Tweel, Maaike van Gerwen, Madeleine Schaberg, Patrick Colley, Anthony Del Signore, Satish Govindaraj, Alfred Marc Iloreta
OBJECTIVE: To evaluate the efficacy of omega-3 fatty acid (O3FA) supplementation in the treatment of COVID-related olfactory dysfunction (OD). METHODS: Patients with laboratory-confirmed or clinically-suspected COVID-19 infection and new-onset OD from August 2020 to November 2021 were prospectively recruited. Patients with quantitative OD, defined as a brief smell identification test (BSIT) score of 9 or less, were eligible for study inclusion. The experimental group received 2 g of O3FA supplementation, while the control group received an identical placebo to be taken daily for 6 weeks...
September 2023: American Journal of Rhinology & Allergy